Continuing Education Information

Target Audience: The intended audience for this activity is psychiatrists, psychologists, social workers, and other mental health clinical professionals treating patients with dissociative disorders.

Accreditation & Credit Designation Statements:

Physician Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Sheppard Pratt Health System and International Society for the Study of Trauma and Dissociation. Sheppard Pratt Health System is accredited by the ACCME to provide continuing medical education for physicians. Sheppard Pratt Health System designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Psychologist Statement: Sheppard Pratt Health System is authorized by the State Board of Examiners of Psychologists as a sponsor of continuing education. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. Sheppard Pratt Health System designates this educational activity for a maximum of 5.0 CEU hours for Psychologists. Psychologists should claim credit commensurate with the extent of their participation in the activity.

Social Worker Statement: Sheppard Pratt Health System is authorized by the Board of Social Work Examiners of Maryland to offer continuing education for Social Workers. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. This activity is approved for 5.0 CEU contact hours in Category 1 credits for Social Workers.

Disclosure Statements:

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers and speakers have been asked to disclose any relationship he /she or their spouse/partner has with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt Health System, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Faculty Disclosures:

Bethany Brand, Ph.D. reports having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients, during the past 12 months. She will not discuss any medications, off-label uses, or other medical products or services in this presentation.

Richard Chefetz, M.D. reports having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients, during the past 12 months. He will not discuss any medications, off-label uses, or other medical products or services in this presentation.

Kathy Steele, MN, CS, APRN reports having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients, during the past 12 months. She will not discuss any medications, off-label uses, or other medical products or services in this presentation.

Richard Loewenstein, M.D. reports having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients, during the past 12 months. He will discuss various classes of psychiatric medications, ECT and TMS, as well as, off-label uses of medications for PTSD, depression, bipolar disorder, psychosis, and impulse control in this presentation. 

Ruth Lanius, M.D., Ph.D. reports having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients, during the past 12 months. She will not discuss any medications, off-label uses, or other medical products or services in this presentation.                 

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months: Ellen Mongan, M.D., Caroline Cahn, LCSW-C, Tom Flis, LCPC, Faith Dickerson, Ph.D., Robert Roca, M.D., Drew Pate, M.D., Meena Vimalananda, M.D., Briana Riemer, M.D., Jennifer Tornabene, and Bonnie Katz.

ACKNOWLEDGEMENTS OF SUPPORT

It is with great appreciation that we wish to acknowledge the in-kind and financial support for this Conference. None of the support offered for this Conference was from a commercial supporter. The ACCME defines a commercial supporter as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

The following speakers donated their honoraria: Bethany Brand, Ph.D., Richard Chefetz, M.D., Kathy Steele, MN, CS, APRN, Richard Loewenstein, M.D., and Ruth Lanius, M.D., Ph.D.

Sheppard Pratt Health System donated the Conference Center space as in-kind support.

Towson University donated funds to be applied to speaker travel costs.